LLY 8-K: Q3 2025 earnings press release furnished
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Eli Lilly and Company furnished an 8-K under Item 2.02 to announce it issued a press release with financial results for the quarter ended September 30, 2025. The press release is attached as Exhibit 99.1 and is incorporated by reference into Item 2.02.
The information in Item 2.02 is being furnished and is not deemed filed for purposes of Section 18 of the Exchange Act. The filing also includes Exhibit 104 for the cover page Inline XBRL. The document identifies Lilly’s listed securities, including common stock (LLY) on the NYSE.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 2.02, 9.01
2 items
Item 2.02
Results of Operations and Financial Condition
Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
FAQ
What did LLY disclose in this 8-K?
LLY furnished Item 2.02 to provide a press release announcing financial results for the quarter ended September 30, 2025, attached as Exhibit 99.1.
Is the earnings information considered filed or furnished?
The Item 2.02 information is furnished and is not deemed filed under Section 18 of the Exchange Act.
Which exhibits are included with the 8-K?
The filing includes Exhibit 99.1 (press release) and Exhibit 104 (Cover Page Inline XBRL data file).
What period does the press release cover?
It covers financial results for the quarter ended September 30, 2025.
Who signed the report for LLY?
It was signed by Donald A. Zakrowski, Senior Vice President, Finance, and Chief Accounting Officer.
On which exchange is LLY common stock listed?
LLY common stock is listed on the New York Stock Exchange under the symbol LLY.